185 related articles for article (PubMed ID: 30600947)
1. Frequency and Implications of Natural Killer and Natural Killer T Cells in Hepatocellular Carcinoma.
Zahran AM; Abdel-Meguid MM; Ashmawy AM; Rayan A; Elkady A; Elsherbiny NM; Hetta HF
Egypt J Immunol; 2018 Jun; 25(2):45-52. PubMed ID: 30600947
[TBL] [Abstract][Full Text] [Related]
2. Diminished absolute counts of CD56dim and CD56bright natural killer cells in peripheral blood from Egyptian patients with hepatocellular carcinoma.
Fathy A; Eldin MM; Metwally L; Eida M; Abdel-Rehim M
Egypt J Immunol; 2009; 16(2):17-25. PubMed ID: 22059350
[TBL] [Abstract][Full Text] [Related]
3. The effects of stereotactic body radiotherapy on peripheral natural killer and CD3
Li TT; Sun J; Wang Q; Li WG; He WP; Yang RC; Duan XZ
Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):240-250. PubMed ID: 33454220
[TBL] [Abstract][Full Text] [Related]
4. The Putative Role of Natural Killer Cells in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.
Hassouna MM; Radwan EM; Abdelsameea E; Estaphan S; Abd Elrhman HE; Abdel-Samiee M; Naguib M
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2559-2567. PubMed ID: 34452571
[TBL] [Abstract][Full Text] [Related]
5. Effect of Transcatheter Arterial Chemoembolization Combined with Argon-Helium Cryosurgery System on the Changes of NK Cells and T Cell Subsets in Peripheral Blood of Hepatocellular Carcinoma Patients.
Huang M; Wang X; Bin H
Cell Biochem Biophys; 2015 Dec; 73(3):787-92. PubMed ID: 27259326
[TBL] [Abstract][Full Text] [Related]
6. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
[TBL] [Abstract][Full Text] [Related]
7. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.
Sung PS; Jang JW
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463262
[TBL] [Abstract][Full Text] [Related]
8. NK, NKT and Invariant-NKT Cells in Tumor Draining Lymph Nodes of Patients with Breast Cancer.
Rezaeifard S; Safaei A; Talei A; Faghih Z; Erfani N
Iran J Immunol; 2019 Dec; 16(4):291-298. PubMed ID: 31885006
[TBL] [Abstract][Full Text] [Related]
9. Expression of Fas antigen (CD95) in peripheral blood lymphocytes and in liver-infiltrating, cytotoxic lymphocytes in patients with hepatocellular carcinoma.
Yuen MF; Hughes RD; Heneghan MA; Langley PG; Norris S
Cancer; 2001 Oct; 92(8):2136-41. PubMed ID: 11596030
[TBL] [Abstract][Full Text] [Related]
10. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
11. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.
Cai L; Zhang Z; Zhou L; Wang H; Fu J; Zhang S; Shi M; Zhang H; Yang Y; Wu H; Tien P; Wang FS
Clin Immunol; 2008 Dec; 129(3):428-37. PubMed ID: 18824414
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells involved in tumour immune escape of hepatocellular carcinomar.
Han C; Jiang Y; Wang Z; Wang H
Int Immunopharmacol; 2019 Aug; 73():10-16. PubMed ID: 31078921
[TBL] [Abstract][Full Text] [Related]
13. IL-21 reinvigorates exhausted natural killer cells in patients with HBV-associated hepatocellular carcinoma in STAT1-depedent pathway.
Jin Y; Sun Z; Geng J; Yang L; Song Z; Song H; Wang J; Tang J
Int Immunopharmacol; 2019 May; 70():1-8. PubMed ID: 30780004
[TBL] [Abstract][Full Text] [Related]
14. [Characteristics of peripheral NK cells in hepatocellular carcinoma patients].
Zhou L; Cai L; Zhang Z; Yang YP; Wang FS
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):136-9. PubMed ID: 20196954
[TBL] [Abstract][Full Text] [Related]
15. Expression of inhibitory receptors in natural killer (CD3(-)CD56(+)) cells and CD3(+)CD56(+) cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma.
Yuen MF; Norris S
Clin Immunol; 2001 Dec; 101(3):264-9. PubMed ID: 11726217
[TBL] [Abstract][Full Text] [Related]
16. Liver-infiltrating CD11b
Zhang QF; Yin WW; Xia Y; Yi YY; He QF; Wang X; Ren H; Zhang DZ
Cell Mol Immunol; 2017 Oct; 14(10):819-829. PubMed ID: 27321064
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients.
Chew V; Tow C; Huang C; Bard-Chapeau E; Copeland NG; Jenkins NA; Weber A; Lim KH; Toh HC; Heikenwalder M; Ng IO; Nardin A; Abastado JP
J Natl Cancer Inst; 2012 Dec; 104(23):1796-807. PubMed ID: 23197495
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion.
Chuang WL; Liu HW; Chang WY
Cancer; 1990 Feb; 65(4):926-30. PubMed ID: 2153437
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.
Tsunematsu H; Tatsumi T; Kohga K; Yamamoto M; Aketa H; Miyagi T; Hosui A; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Int J Cancer; 2012 Jan; 130(2):356-64. PubMed ID: 21351090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]